Commencing 1 April 2023, the price of Novorapid^® (insulin aspart) as listed under item code 8571D on the Pharmaceutical Benefits Scheme (PBS) has been reduced.

The price for 8571D that appears in the 1 April 2023 PBS Schedule is incorrect. Please see the following erratum which has been published to correct the pricing of this brand in the PBS Schedule for 1 April 2023.

Pricing information for NovoRapid^® in the above erratum supersedes any previous pricing information published on this website. The correct pricing will appear in the PBS Schedule for 1 May 2023.